cp wire

CP Wire Articles

AI Digital Pathology Company Closes $8.3 Million Series A Round

Proscia announced on 9/26/18 that it has closed an $8.3 million round of Series A financing from a group of East and West Coast venture capital firms. The funding was led by Boston-based Flybridge... read more

Wed, 09/26/18 - 09:29 am
Catabasis Pharmaceuticals Initiates Ph III Trial for Promising Duchenne Muscular Dystrophy Drug
  • Edasalonexent has orphan drug status in the US and Europe
  • It has been fast-track status in the US

Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB) announced on 9/25/18 the... read more

Tue, 09/25/18 - 10:12 am
Data Confirms AstraZeneca's Imfinzi Provides Unprecedented Improvement in Progression-Free Survival in Non-Small Cell Lung Cancer
  • Imfinzi is currently approved in the US for the treatment of patients with unresectable Stage III NSCLC whose disease has not progressed following concurrent platinum-based chemotherapy and... read more
Tue, 09/25/18 - 09:51 am
Takeda Presents Superior Results for Alunbrig in ALK+ Non-Small Cell Lung Cancer
  • Alunbrig achieved a 51% increase in progression free survival compared to crizotinib
  • Alunbrig received Breakthrough Therapy Designation from the FDA for the treatment of patients... read more
Tue, 09/25/18 - 09:33 am
Innovation Pharmaceuticals Provides a Comparative Perspective on Brilacidin’s Potential to Unlock the Huge Oral Mucositis Market
  • Oral mucositis is potentially a 1 billion dollar market
  • Additional expenses incurred by patients suffering from SOM are estimated to be as high as $18,000 to $25,000 per case in the... read more
Mon, 09/24/18 - 10:13 am

Pages